Valneva announces successful outcome of its annual general meeting, confirms fy 2025 guidance

Saint-herblain (france), june 25, 2025 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that all the resolutions recommended by the board of directors were approved by the shareholders at its annual general meeting held today in lyon, france.
VALN Ratings Summary
VALN Quant Ranking